Vasoactive intestinal peptide synergizes with TNF-α in inducing human dendritic cell maturation

Journal of Immunology

Volumn 163, Issue 6, 1999, Pages 3071-3075

  Delneste, Yves ^a   Herbault, Nathalie ^a   Galea, Brice ^a   Magistrelli, Giovanni ^a   Bazin, Ingrid ^a   Bonnefoy, Jean Yves ^a   Jeannin, Pascale ^a,b  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b Centre d'Immunologie Pierre Fabre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; NEUROIMMUNOLOGY; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; DENDRITIC CELLS; DRUG SYNERGISM; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033568413     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Goetzl, E. J., R. R. Pankhaniya, G. O. Gaufo, Y. Mu, M. Xia, and S. P. Sreedharan. 1998. Selectivity of effects of vasoactive intestinal peptide on macrophages and lymphocytes in compartmental immune responses. Ann. NY Acad. Sci. 840:540.
2. Calvo, J. R., D. Pozo, and J. M. Guerrero. 1996. Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems. Adv. Neurosci. 6:39.
3. Harmar, A. J., A. Arimura, I. Gozes, L. Journot, M. Laburthe, J. R. Pisegna, S. R. Rawlings, P. Robberecht, S. I. Said, S. P. Sreedharan, et al. 1998. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:265.
4. Ottaway, C. A. 1987. Selective effects of vasoactive intestinal peptide on the mitogenic response of mutine T cells. Immunology 62:291.
5. Boudard, F., and M. Bastide. 1991. Inhibition of mouse T cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis. J. Neurosci. Res. 29:29.
6. Ganea, D., and L. Sun. 1993. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFNγ from stimulated murine T lymphocytes. J. Neurosci. 47:147.
7. Ganea, D., and L. Sun. 1993. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J. Neurosci. 48:59.
8. Delgado, M., C. Martinez, D. Pozzo, L. Leceta, J. R. Calvo, D. Ganea, and R. P. Gomariz. 1998. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide modulate endotoxin induced IL-6 production by murine peritoneal macrophages. J. Leukocyte Biol. 63:591.
9. Xin, Z., and S. Sriram. 1998. Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages. J. Neuroimmunol. 89:206.
10. 25-1553 inhibits the production of TNF and IL-12 by LPS activated monocytes. Immunol. Lett. 60:57.
11. Delgado, M., C. Martinez, D. Pozzo, J. R. Calvo, J. Leceta, D. Ganea, and R. P. Gomariz. 1999. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J. Immunol. 162:1200.
12. Kimata, H., A. Yoshida, M. Fujimoto, and H. Mikawa. 1993. Effect of vasoactive intestinal peptide, somatostatin and substance P on spontaneous IgE and IgG4 production in atopic patients. J. Immunol. 150:4630.
13. Hassner, A., M. S. Matthew, E. J. Goetzl, and D. C. Adelman. 1993. Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. J. Allergy Clin. Immunol. 92:891.
14. Piotrowsky, W., and J. C. Foreman. 1985. On the action of substance P, somatostatin, and vasoactive intestinal peptide on rat peritoneal mast cells and in human skin. Naunyn-Schmiedeberg's Arch. Pharmacol. 331:364.
15. Dalsgaard, C. J., A. Hultgardh-Nilsson, A. Haegerstrand, and J. Nilsson. 1989. Neuropeptides as growth factors: possible roles in human diseases. Regul. Pept. 25:1.
16. Pincelli, C., F. Fantini, P. Romualdi, C. Sevignani, G. Lesa, L. Benassi, and A. Gianetti. 1992. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J. Invest. Dermatol. 98:421.
17. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25.
18. Sella, M., F. Sallustro, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
19. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
20. Roake, J. A., A. S. Rao, P. J. Morris, C. P. Larsen, D. F. Hankins, and J. M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237.
21. De Saint-Vis, B., I. Fugier-Vivier, C. Massacrier, C. Gaillard, B. Vanbervielt, S. Ait-Yahia, J. Banchereau, Y.-J., Liu, S. Lebecque, and C. Caux. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160:1666.
22. Fishbein, V. A., D. H. Coy, S. J. Hocart, N. Y. Jiang, J. E. Mrozinski, S. A. Mantey, and R. T. Jensen. 1994. A chimeric VIP-PACAP analogue but not VIP pseudopeptides function as VIP receptor antagonists. Peptide 15:95.
23. + dendritic cells. Proc. Natl. Acad. Sci. USA 93:2588.
24. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747.
25. 2 and tumor necrosis factor cooperate to activate human dendritic cells: synergislic activation of IL-12 production. J. Exp. Med. 186:1603.
26. Kelleher, P., and S. C. Knight. 1998. IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. Int. Immunol. 10:749.
27. Steinbrink, K., M. Wolf, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772.
28. Nio, D. A., R. N. Moylan, and J. K. Roche. 1993. Modulation of T lymphocyte function by neuropeptides: evidence for their role as local immunoregulatory elements. J. Immunol. 150:5281.
29. Jabrane-Ferrat N., D. Bloom, A. Wu, L. Li, D. Lo, S. P. Sreedharan, C. W. Turck, and E. J. Goetzl. 1999. Enhancement by vasoactive intestinal peptide of γ-interferon production by antigen-stimulated type 1 helper T cells. FASEB J. 13:347.
30. Torii, H., Z. Yan, J. Hosoi, and R. D. Granstein. 1997. Expression of neurotrophic factors and neuropeptide receptors by epidermal Langerhans cells and the Langerhans cell-like line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J. Invest. Dermatol. 109:586.
31. Asahina, A., O. Moro, J. Hosoi, E. A. Lerner, S. Xu, A. Takashima, and R. D. Granstein. 1995. Specific induction of cAMP in Langerhans cells by calcitonin gene-related peptide: relevance to functional effects. Proc. Natl. Acad. Sci. USA 92:8323.
32. Hosoi, J., G. F. Murphy, C. L. Egan, E. A. Lerner, S. Grabbe, A. Asahina, and R. D. Granstein. 1993. Regulation of Langerhans cells function by nerves containing calcitonin gene-related peptide. Nature 363:159.
33. Fiers, W. 1991. Tumor necrosis factor. Characterization at the molecular, cellular, and in vivo level. FEBS Lett. 285:199.
34. Sreedharan, S. P., J.-X. Huang, M. C. Cheung, and E. J. Goetzl. 1995. Structure, expression, and chromosomal localization of the type I human vasoactive peptide receptor gene. Proc. Natl. Acad. Sci. USA 92:2939.
35. Lorenz, J. J., P. J. Furden, J. D. Taylor, M. W. Verghese, G. Chandra, T. A. Kost, S. A. Haneline, L. A. Roner, and J. G. Gray. 1995. A cyclic adenosine 3′, 5′-monophosphate signal is required for the induction of IL-1β by TNF-α in human monocytes. J. Immunol. 155:836.
36. Delgado, M., E. J. Munoz-Elias, R. P. Gomariz, and D. Ganea. 1999. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J. Immunol. 162:1707.
37. Allavena, P., L. Piemonti, D. Longoni, S. Bernasconi, A. Stoppacciaro, L. Ruco, and A. Mantovani. 1998. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28:359.